U.S. pharma giant copyright scrapped two experimental weight loss products final yr—a as soon as-everyday capsule, lotiglipron, as a consequence of elevated liver enzymes along with a 2 times-each day tablet, danuglipron, due to strong Unwanted side effects—but CEO Albert Bourla has